Friday, Johnson & Johnson (NYSE:JNJ) agreed to acquire Shockwave Medical Inc (NASDAQ:SWAV) for $335.00 per share in cash, corresponding to an enterprise value of approximately $13.1 billion, including cash acquired.
The acquisition comes a little more than a year, when in 2022, Johnson & Johnson acquired Abiomed for an upfront payment of $380.00 per share in cash, corresponding to an enterprise value of approximately $16.6 billion.
In November 2023, Johnson & Johnson MedTech acquired Laminar Inc., a privately-held medical device company focused on eliminating the left atrial appendage in patients with non-valvular atrial fibrillation, for $400 million.
The acquisition of Shockwave Medical further extends Johnson & Johnson MedTech’s position in cardiovascular intervention and ...